Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions

PHASE3CompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

November 30, 2016

Conditions
Chronic Troublesome SialorrheaParkinson's DiseasePost-strokeTraumatic Brain Injury
Interventions
DRUG

IncobotulinumtoxinA (100 Units)

Active ingredient: Clostridium Botulinum neurotoxin Type A free from complexing proteins. Solution for injection prepared by reconstitution of powder with 0.9% Sodium Chloride (NaCl).

DRUG

IncobotulinumtoxinA (75 Units)

Active ingredient: Clostridium Botulinum neurotoxin Type A free from complexing proteins. Solution for injection prepared by reconstitution of powder with 0.9% Sodium Chloride (NaCl).

DRUG

Placebo

Solution for injection prepared by reconstitution of powder with 0.9% Sodium Chloride (NaCl).

Trial Locations (31)

51588

Merz Investigational Site #049300, Nümbrecht

53105

Merz investigational site #049172, Bonn

77709

Merz Investigational Site #049333, Wolfach

80804

Merz Investigational Site #049072, Munich

81675

Merz Investigational Site #049148, Munich

83527

Merz Investigational Site #049337, Haag i.OB

89081

Merz Investigational Site #049143, Ulm

93053

Merz Investigational Site #049303, Regensburg

97080

Merz Investigational Site #049302, Würzburg

07551

Merz Investigational Site #049335, Gera

07646

Merz investigational site #049348, Stadtroda

85-015

Merz investigational site #048068, Bydgoszcz

85-080

Merz Investigational Site #048088, Bydgoszcz

80-254

Merz Investigational Site #048029, Gdansk

80-546

Merz investigational site #048074, Gdansk

43-600

Merz investigational site #048078, Jaworzno

40-097

Merz investigational site #048076, Katowice

Merz investigational site #048077, Katowice

25-103

Merz investigational Site #048067, Kielce

30-539

Merz investigational site #048059, Krakow

Merz investigational site #048085, Lublin

31-505

Merz investigational site #048031, Krakow

31-530

Merz Investigational Site #048087, Krakow

90-130

Merz Investigational Site #048022, Lodz

20-718

Merz investigational site #048070, Lublin

62-030

Merz investigational site #048072, Luboń

27-600

Merz Investigational Site #048075, Sandomierz

87-100

Merz Investigational Site #048086, Torun

00-453

Merz investigational site #048065, Warsaw

02-097

Merz investigational site #048056, Warsaw

03-242

Merz investigational site #048064, Warsaw

Sponsors
All Listed Sponsors
lead

Merz Pharmaceuticals GmbH

INDUSTRY

NCT02091739 - Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions | Biotech Hunter | Biotech Hunter